nach oben

Pathology & Oncology Research

Erschienen in:

01.05.2017 | Original Article

Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion

verfasst von: Mohammad Reza Abbaszadegan, Meysam Moghbeli

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Homeobox (HOX) transcription factors and NOTCH signaling pathway are critical regulators of stem cell functions, cell fate in development and homeostasis of gastrointestinal tissues. In the present study, we analyzed cross talk between NOTCH pathway and HOX genes through assessment of probable correlation betweenMAML1 and MEIS1 as the main transcription factor of NOTCH pathway and enhancer of HOX transcriptional machinery, respectively in esophageal squamous cell carcinoma (ESCC) patients. Fifty one ESCC cases were enrolled to assess the levels of Meis1 and Maml1 mRNA expression using real-time polymerase chain reaction (PCR). Only 3 out of 51 (5.9%) cases had MEIS1/MAML1 under expression and 2/51 (3.9%) cases had MEIS1/MAML1over expression. Nine out of 51 samples (17.6%) have shown MEIS1 under expression and MAML1 over expression. There was a significant correlation between MAML1and MEIS1mRNA expressions (p ≤ 0.05). There were significant correlations between MEIS1 under/MAML1 over expressed cases and tumor location (p = 0.05), tumor depth of invasion (p = 0.011), and sex (p = 0.04). Our results showed that MEIS1 may have a negative role in regulation of MAML1expression during the ESCC progression.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107 CrossRefPubMed

Moghbeli M, Abbaszadegan MR, Farshchian M, Montazer M, Raeisossadati R, Abdollahi A, Forghanifard MM (2013) Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Med Oncol 30(2):516CrossRefPubMed

Moghbeli M, Abbaszadegan MR, Golmakani E, Forghanifard MM (2016) Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J Cell Commun Signal 10(2):129–135CrossRefPubMedPubMedCentral

Moghbeli M, Forghanifard MM, Sadrizadeh A, Mozaffari HM, Golmakani E, Abbaszadegan MR (2015) Role of Msi1 and MAML1 in regulation of notch signaling pathway in patients with esophageal squamous cell carcinoma. J Gastrointest Cancer 46(4):365–369CrossRefPubMed

Moghbeli M, Moghbeli F, Forghanifard MM, Garayali A, Abbaszadegan MR (2013) Cancer stem cell markers in esophageal cancer. American Journal of Cancer Science 2(1):37–50

Moghbeli M, Rad A, Farshchian M, Taghehchian N, Gholamin M, Abbaszadegan MR (2016) Correlation between Meis1 and Msi1 in esophageal squamous cell carcinoma. J Gastrointest Cancer 47(3):273–277CrossRefPubMed

Moghbeli M, Sadrizadeh A, Forghanifard MM, Mozaffari HM, Golmakani E, Abbaszadegan MR (2016) Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion. J Cell Commun Signal 10(1):49–53CrossRefPubMed

Taleb S, Abbaszadegan MR, Moghbeli M, Roudbari NH, Forghanifard MM (2014) HES1 as an independent prognostic marker in esophageal squamous cell carcinoma. J Gastrointest Cancer 45(4):466–471CrossRefPubMed

Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415):770–776CrossRefPubMed

10.

Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD (1999) CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A 96(1):23–28CrossRefPubMedPubMedCentral

11.

Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T (1998) A histone deacetylase corepressor complex regulates the notch signal transduction pathway. Genes Dev 12(15):2269–2277CrossRefPubMedPubMedCentral

12.

Taniguchi Y, Furukawa T, Tun T, Han H, Honjo T (1998) LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol Cell Biol 18(1):644–654CrossRefPubMedPubMedCentral

13.

Oswald F, Tauber B, Dobner T, Bourteele S, Kostezka U, Adler G, Liptay S, Schmid RM (2001) p300 acts as a transcriptional coactivator for mammalian notch-1. Mol Cell Biol 21(22):7761–7774. doi:10.1128/MCB.21.22.7761-7774.2001 CrossRefPubMedPubMedCentral

14.

Kurooka H, Honjo T (2000) Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5. J Biol Chem 275(22):17211–17220. doi:10.1074/jbc.M000909200 CrossRefPubMed

15.

Wu L, Sun T, Kobayashi K, Gao P, Griffin JD (2002) Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 22(21):7688–7700CrossRefPubMedPubMedCentral

16.

Kitagawa M, Oyama T, Kawashima T, Yedvobnick B, Kumar A, Matsuno K, Harigaya K (2001) A human protein with sequence similarity to drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters. Mol Cell Biol 21(13):4337–4346. doi:10.1128/MCB.21.13.4337-4346.2001 CrossRefPubMedPubMedCentral

17.

Lin SE, Oyama T, Nagase T, Harigaya K, Kitagawa M (2002) Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 277(52):50612–50620. doi:10.1074/jbc.M209529200 CrossRefPubMed

18.

Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD (2000) MAML1, a human homologue of drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26(4):484–489. doi:10.1038/82644 CrossRefPubMed

19.

Jeffries S, Robbins DJ, Capobianco AJ (2002) Characterization of a high-molecular-weight notch complex in the nucleus of notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol Cell Biol 22(11):3927–3941CrossRefPubMedPubMedCentral

20.

Saint Just Ribeiro M, Hansson ML, Wallberg AE (2007) A proline repeat domain in the notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. Biochem J 404(2):289–298. doi:10.1042/BJ20061900 CrossRefPubMedPubMedCentral

21.

Owens BM, Hawley RG (2002) HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20(5):364–379CrossRefPubMed

22.

Sitwala KV, Dandekar MN, Hess JL (2008) HOX proteins and leukemia. Int J Clin Exp Pathol 1(6):461–474PubMedPubMedCentral

23.

Cillo C, Cantile M, Faiella A, Boncinelli E (2001) Homeobox genes in normal and malignant cells. J Cell Physiol 188(2):161–169CrossRefPubMed

24.

Goh SL, Looi Y, Shen H, Fang J, Bodner C, Houle M, Ng AC, Screaton RA, Featherstone M (2009) Transcriptional activation by MEIS1A in response to protein kinase a signaling requires the transducers of regulated CREB family of CREB co-activators. J Biol Chem 284(28):18904–18912CrossRefPubMedPubMedCentral

25.

Huang H, Rastegar M, Bodner C, Goh SL, Rambaldi I, Featherstone M (2005) MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J Biol Chem 280(11):10119–10127CrossRefPubMed

26.

Wang Z, Iwasaki M, Ficara F, Lin C, Matheny C, Wong SH, Smith KS, Cleary ML (2010) GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis. Cancer Cell 17(6):597–608CrossRefPubMedPubMedCentral

27.

Boucherat O, Chakir J, Jeannotte L (2012) The loss of Hoxa5 function promotes notch-dependent goblet cell metaplasia in lung airways. Biol Open 1(7):677–691CrossRefPubMedPubMedCentral

28.

Chariot A, Gielen J, Merville MP, Bours V (1999) The homeodomain-containing proteins: an update on their interacting partners. Biochem Pharmacol 58(12):1851–1857CrossRefPubMed

29.

Esparza SD, Chang J, Shankar DB, Zhang B, Nelson SF, Sakamoto KM (2008) CREB regulates Meis1 expression in normal and malignant hematopoietic cells. Leukemia 22(3):665–667. doi:10.1038/sj.leu.2404933 CrossRefPubMed

30.

Ferretti E, Villaescusa JC, Di Rosa P, Fernandez-Diaz LC, Longobardi E, Mazzieri R, Miccio A, Micali N, Selleri L, Ferrari G, Blasi F (2006) Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol 26(15):5650–5662. doi:10.1128/MCB.00313-06 CrossRefPubMedPubMedCentral

31.

Moghbeli M, Maleknejad M, Arabi A, Abbaszadegan MR (2012) Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria. Mol Biol Rep 39(6):6731–6735CrossRefPubMed

32.

Forghanifard MM, Moghbeli M, Raeisossadati R, Tavassoli A, Mallak AJ, Boroumand-Noughabi S, Abbaszadegan MR (2013) Role of SALL4 in the progression and metastasis of colorectal cancer. J Biomed Sci 20:6CrossRefPubMedPubMedCentral

33.

Forghanifard MM, Moaven O, Farshchian M, Montazer M, Raeisossadati R, Abdollahi A, Moghbeli M, Nejadsattari T, Parivar K, Abbaszadegan MR (2012) Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis. Ann Surg Oncol 19(3):743–749CrossRefPubMed

34.

Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR (2005) The pathophysiology of HOX genes and their role in cancer. J Pathol 205(2):154–171. doi:10.1002/path.1710 CrossRefPubMed

35.

Wermuth PJ, Buchberg AM (2005) Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 105(3):1222–1230. doi:10.1182/blood-2004-03-0802 CrossRefPubMed

36.

Yamashita T, Tazawa S, Yawei Z, Katayama H, Kato Y, Nishiwaki K, Yokohama Y, Ishikawa M (2006) Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells. Int J Oncol 28(4):931–938PubMed

37.

Argiropoulos B, Yung E, Humphries RK (2007) Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev 21(22):2845–2849. doi:10.1101/gad.1619407 CrossRefPubMed

38.

Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP (2001) Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci U S A 98(23):13120–13125. doi:10.1073/pnas.231115398 CrossRefPubMedPubMedCentral

39.

Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q, Lund EA, Wu B, Kowal BJ, Kersey JH (2009) A role for MEIS1 in MLL-fusion gene leukemia. Blood 113(8):1756–1758. doi:10.1182/blood-2008-06-163287 CrossRefPubMedPubMedCentral

40.

Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17(8):2215–2223. doi:10.1093/emboj/17.8.2215 CrossRefPubMedPubMedCentral

41.

Lindahl T, Satoh MS, Poirier GG, Klungland A (1995) Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20(10):405–411CrossRefPubMed

42.

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4):479–489CrossRefPubMed

43.

Brinkmann U, Brinkmann E, Gallo M, Pastan I (1995) Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc Natl Acad Sci U S A 92(22):10427–10431CrossRefPubMedPubMedCentral

Titel: Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion
verfasst von: Mohammad Reza Abbaszadegan
Meysam Moghbeli
Publikationsdatum: 01.05.2017
Verlag: Springer Netherlands
Erschienen in: Pathology & Oncology Research / Ausgabe 2/2018
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-017-0243-1

Springer Medizin

Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Downregulation of lncRNA TUBA4B is Associated with Poor Prognosis for Epithelial Ovarian Cancer

Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery

Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma

Expression of Hypoxia-Associated Protein HIF-1α in Follicular Thyroid Cancer is Associated with Distant Metastasis

Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case- Control Study in Two Community Hospitals

Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie